DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

DSLT enables newly diagnosed patients to remain well controlled and off medications

Inclusion Criteria:

• Primary open angle glaucoma
• Patients age 30 or greater with an IOP of 18-26 mmHg
• Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
• DSLT procedure

Exclusion Criteria:

• History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
• Angle closure patients
• Ocular Hypertension
• Baseline VF MD of worse than -12dB
• Uncontrolled systemic microvascular disease (eg. HTN, DM)
• Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

55 Treatment naïve (including medication in either eye, previous laser or surgery) mild to moderate POAG subjects

Upon completion of the study collection, the investigators will share the findings of the DSLT treatment with other researchers to then be published

The data will be available after the study is completed tentatively 12/2026 and available for 12 months until 12/2027.

The investigators will allow other researchers to contact us for information and the study results, the final results is the only thing that others will have access to upon request.